Compare MBOT & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBOT | HSDT |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9M | 102.2M |
| IPO Year | 2000 | N/A |
| Metric | MBOT | HSDT |
|---|---|---|
| Price | $1.91 | $1.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.50 | $4.00 |
| AVG Volume (30 Days) | ★ 782.4K | 399.7K |
| Earning Date | 05-15-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.27 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,887.00 | N/A |
| Revenue This Year | N/A | $91.56 |
| Revenue Next Year | $119.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $1.19 |
| 52 Week High | $4.62 | $25.50 |
| Indicator | MBOT | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 52.06 | 53.53 |
| Support Level | $1.65 | $1.78 |
| Resistance Level | $2.21 | $1.80 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 54.62 | 76.09 |
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.